Who owns the KOMRILU trademark?

The KOMRILU trademark is owned by Glaxo Group Limited.

What class is the KOMRILU trademark registered in?

The KOMRILU trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for KOMRILU?

The USPTO serial number for KOMRILU is 79280370.

What is the registration number for KOMRILU?

KOMRILU is registered under USPTO registration number 6121500.

Sealvo

Home Search: KOMRILUKOMRILU #79280370

Back

Updated Oct 7, 2026·25 searches this week

View on USPTO TSDR Find similar marks

KOM

USPTO Trademark Record

REGISTERED

KOMRILU

SN 79280370·Reg 6121500·Filed Jan 13, 2020

Owner Glaxo Group Limited

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

KOMRILU (Serial No. 79280370), Registration No. 6121500, is a registered US trademark filed on Jan 13, 2020 by Glaxo Group Limited. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

renewal grace 6y period: February 11, 2027126 days remaining

Mark Intelligence

KOMRILU (Reg. #6121500) is a registered US trademark that has been protecting its owner, Glaxo Group Limited, since 2020. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Jan 13, 2020

SERIAL

79280370

REG#

6121500

REGISTERED

Aug 11, 2020

Filing Information

StatusREGISTERED

Filing DateJan 13, 2020

Serial Number79280370

Registration No.6121500

Registration DateAug 11, 2020

Status DateAug 11, 2020

Published for OppositionMay 26, 2020

Filing Basis & Declarations

Standard Characters ClaimedTrademark

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 006, 018, 044, 046, 051, 052

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

25 events

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

Aug 11, 2025

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

NEW REPRESENTATIVE AT IB RECEIVED

Jun 05, 2025

NEW REPRESENTATIVE AT IB RECEIVED

CHANGE OF NAME/ADDRESS REC'D FROM IB

Jul 28, 2023

CHANGE OF NAME/ADDRESS REC'D FROM IB

FINAL DECISION TRANSACTION PROCESSED BY IB

Dec 12, 2020

FINAL DECISION TRANSACTION PROCESSED BY IB

FINAL DISPOSITION PROCESSED

Nov 24, 2020

FINAL DISPOSITION PROCESSED

FINAL DISPOSITION NOTICE SENT TO IB

Nov 24, 2020

FINAL DISPOSITION NOTICE SENT TO IB

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

Nov 11, 2020

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

REGISTERED-PRINCIPAL REGISTER

Aug 11, 2020

REGISTERED-PRINCIPAL REGISTER

PUBLISHED FOR OPPOSITION

May 26, 2020

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

May 26, 2020

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

May 06, 2020

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

REFUSAL PROCESSED BY IB

Apr 18, 2020

REFUSAL PROCESSED BY IB

ASSIGNED TO LIE

Apr 17, 2020

ASSIGNED TO LIE

APPROVED FOR PUB - PRINCIPAL REGISTER

Apr 08, 2020

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Apr 07, 2020

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Apr 07, 2020

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Apr 07, 2020

TEAS/EMAIL CORRESPONDENCE ENTERED

REFUSAL PROCESSED BY MPU

Mar 28, 2020

REFUSAL PROCESSED BY MPU

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

Mar 28, 2020

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

Mar 19, 2020

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

NON-FINAL ACTION WRITTEN

Mar 18, 2020

NON-FINAL ACTION WRITTEN

ASSIGNED TO EXAMINER

Mar 15, 2020

ASSIGNED TO EXAMINER

APPLICATION FILING RECEIPT MAILED

Mar 13, 2020

APPLICATION FILING RECEIPT MAILED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Mar 09, 2020

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

SN ASSIGNED FOR SECT 66A APPL FROM IB

Mar 05, 2020

SN ASSIGNED FOR SECT 66A APPL FROM IB

Other Marks by Glaxo Group Limited

Additional USPTO filings from the same owner.

KOS

KOSPRIZTO

99535749

Glaxo Group Limited

REGISTERED

KYB

KYBRAKU

99535750

Glaxo Group Limited

REGISTERED

EQP

EQPANZO

99535752

Glaxo Group Limited

REGISTERED

HON

HONMOZA

99535758

Glaxo Group Limited

REGISTERED

Other Marks by Merilee J. Arevalo

Additional USPTO filings handled by the same attorney of record.

VII

VIIV HEALTHCARE

90781713

REGISTERED

VII

VIIV HEALTHCARE

90781712

REGISTERED

DEX

DEXUVE

79261531

REGISTERED

LUM

LUMYDE

79261301

REGISTERED

KOMRILU

Run a conflict check

Other Marks by Glaxo Group Limited

Other Marks by Merilee J. Arevalo

Get pre-filing clearance

Search 14M+ trademarks

Resources

Company